Details for New Drug Application (NDA): 202861
✉ Email this page to a colleague
The generic ingredient in MORPHINE SULFATE is morphine sulfate. There are twenty-three drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.
Summary for 202861
Tradename: | MORPHINE SULFATE |
Applicant: | Intl Medication Sys |
Ingredient: | morphine sulfate |
Patents: | 0 |
Pharmacology for NDA: 202861
Mechanism of Action | Full Opioid Agonists |
Medical Subject Heading (MeSH) Categories for 202861
Suppliers and Packaging for NDA: 202861
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MORPHINE SULFATE | morphine sulfate | INJECTABLE;INJECTION | 202861 | ANDA | International Medication Systems, Limited | 76329-1912 | 76329-1912-1 | 1 VIAL in 1 CARTON (76329-1912-1) / 30 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 1MG/ML | ||||
Approval Date: | Apr 29, 2021 | TE: | RLD: | No |
Complete Access Available with Subscription